1-6 of 6
Jeffrey Johnson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Frontline R-CHOP and BR Have Similar Outcomes By SUV max in Follicular Lymphoma

Patrizia Mondello, Brianna J Negaard, Luca Arcaini, Joshua Tobin, Loic Chartier, Brian K. Link, Andrew L. Feldman, Dai Chihara, Carla Casulo, Anne Ségolène Cottereau, Luca Guerra, Joshua Olson, Jason T Romancik, Sara Haddadi, Harrison Black, Thomas Trevis, Eric Mou, Tsz Hung Tong, Kamilia Moalem, Anna M. Johnston, Paul J. Hampel, Jeffrey Johnson, Steinepreis Elizabeth, Pinguang Yang, Serena Kosciejew, Goodall Elizabeth, Kate Manos, Chan Y. Cheah, Ross Salvaris, Thomas M. Habermann, Peter Martin, Brad S. Kahl, Grzegorz S. Nowakowski, Georgina Hodges, Loretta Nastoupil, Dipti Talaulikar, Judith Trotman, James R. Cerhan, Christopher R. Flowers, Izidore S. Lossos, Richard Burack, Stefano Luminari, Franck Morschhauser, Stephen M. Ansell, Matthew J. Maurer
Journal: Blood
Blood (2024) 144 (Supplement 1): 3007.
https://doi.org/10.1182/blood-2024-202088
Published: 2024
Journal Articles

Minimal Residual Disease (MRD) Status Following Induction Chemo-Immunotherapy Predicts Progression-Free Survival In Mantle Cell Lymphoma (MCL): CALGB 50403 (Alliance)

Noreen Fulton, B.S., Jeffrey Johnson, M.S., Lawrence D. Kaplan, M.D., Greg Koval, B.S., Greg Malnassy, B.S., Sin-Ho Jung, Ph.D., Steve Devine, M.D., Thomas C. Shea, M.D., John P. Leonard, M.D., Bruce D. Cheson, M.D., Wendy Stock, M.D.
Journal: Blood
Blood (2013) 122 (21): 3002.
https://doi.org/10.1182/blood.V122.21.3002.3002
Published: 2013
Journal Articles

Salvage Therapy with Bortezomib Plus Lenalidomide for Relapsed/Refractory Mantle Cell Lymphoma: Initial Results of a Phase II Trial (Alliance/CALGB 50501)

Vicki A. Morrison, MD, Sin-Ho Jung, PhD, Jeffrey Johnson, MS, Ann LaCasce, MD, Kristie A. Blum, MD, Nancy L. Bartlett, MD, Bruce D. Cheson, MD
Journal: Blood
Blood (2012) 120 (21): 3696.
https://doi.org/10.1182/blood.V120.21.3696.3696
Published: 2012
Journal Articles

Daunorubicin Dose Intensification during Treatment of Adult Acute Lymphoblastic Leukemia (ALL): Final Results from Cancer and Leukemia Group B Study 19802.

Wendy Stock, MD, Jeffrey Johnson, MS, Daohai Yu, PhD, Diane Bennett, BSN, Dorie Sher, BS, Richard M. Stone, MD, Jonathan E. Kolitz, MD, Bayard L. Powell, MD, Meir Wetzler, MD, James W. Vardiman, MD, Clara D. Bloomfield, MD, Richard A. Larson, MD
Journal: Blood
Blood (2005) 106 (11): 1833.
https://doi.org/10.1182/blood.V106.11.1833.1833
Published: 2005
Journal Articles

Phase II Study of Thalidomide in Escalating Doses for Follicular (F-NHL) and Small Lymphocytic Lymphoma (Sll): CALGB Study 50002.

David L. Grinblatt, M.D., Jeffrey Johnson, Donna Niedzwicki, Ph.D., David A. Rizzieri, M.D., Nancy Bartlett, M.D., Bruce D. Cheson, M.D.
Journal: Blood
Blood (2004) 104 (11): 3284.
https://doi.org/10.1182/blood.V104.11.3284.3284
Published: 2004
Journal Articles

Eradication of Minimal Residual Disease during Treatment of Mantle Cell Lymphoma: CALGB 59909.

Dorie Sher, BS, Jeffrey Johnson, PhD, Mariah Siddiqui, Michael A. Caligiuri, MD, Lloyd E. Damon, MD, George P. Canellos, MD, Charles Linker, MD, Bruce D. Cheson, MD, Wendy Stock, MD
Journal: Blood
Blood (2004) 104 (11): 1652.
https://doi.org/10.1182/blood.V104.11.1652.1652
Published: 2004